4-part series to help your company write a winning SBIR/STTR proposal.
SBIRs are one of the most common non-dilutive funding mechanisms to help life science startups get started.
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are highly competitive programs that encourage domestic small businesses to engage in Federal Research/Research and Development (R/R&D) with the potential for commercialization. Through a competitive awards-based program, SBIR and STTR enable small businesses to explore their technological potential and provide the incentive to profit from its commercialization. By including qualified small businesses in the nation's R&D arena, high-tech innovation is stimulated, and the United States gains entrepreneurial spirit as it meets its specific research and development needs.
Join SBIR experts from Eva Garland Consulting for this in-depth 4-part series to help your company write a winning proposal.
Part 1: Overview of SBIR/STTR Proposals
Part 2: Budgeting & Building Your Team
Part 3: Writing your Research Strategy
Part 4: Commercialization Plans
Dr. Chelcie Heaney has strong behavioral and molecular neuroscience expertise, including preclinical animal models and mechanisms affecting molecular translation. Her previous research included elucidating the role of inhibitory signaling in learning and memory processes, identifying the key molecular mechanisms associated with the efficacy of rapid antidepressants, utilizing bioinformatics to identify FDA-approved medicines predicted to treat major depression in autism, and examining how major depressive disorder and alcohol use disorders co-occur, with an emphasis on adolescent vulnerability. Dr. Heaney’s work has been supported by various funding sources, including a Graduate Student Scholarship from the American Psychological Foundation and Council of Graduate Departments of Psychology, a National Institutes of Health (NIH) T32 Training Grant from Wake Forest University School of Medicine’s Department of Neuroscience, and a Postdoctoral Fellowship from the Fragile X Research Foundation. At EGC, Dr. Heaney enjoys collaborating with scientists with diverse training backgrounds, and helping clients obtain funding to develop their groundbreaking technologies. In her free time, Dr. Heaney enjoys cooking and baking, solving cryptic crosswords, and exploring the culinary offerings of the cities around her.
Dr. Brandon Turner provides a broad range of scientific expertise ranging from neuronal physiology to animal behavior to molecular biology and genetics. Dr. Turner is an experienced Manuscript Editor and Science Writer, and his many awards include a National Institutes of Health (NIH) F31 Institutional Training Grant at Vanderbilt University and a postdoctoral F32 NRSA through the NIH BRAIN Initiative at Duke University. Dr. Turner has a strong passion for helping scientists design and complete novel and exciting projects. In his current position at EGC, Dr. Turner enjoys the unique opportunity to support entrepreneurs and small businesses in developing new technologies and innovations. In his free time, Dr. Turner enjoys cooking with his family, reading, biking, and spending time outdoors with his dogs.
Eva Garland Consulting (EGC) assists small businesses in securing resources to accelerate development of their innovative technologies. We provide expert advisory services for our clients in developing strategic plans for securing non-dilutive funding; preparing winning grant applications; and establishing efficient infrastructures that are compliant with the terms of funding agencies.
Our team of Scientific Consultants specialize in identifying and securing resources to support scientific advancement. We provide customized strategies for obtaining non-dilutive SBIR/STTR grant funding through Federal agencies including NIH, DoD, NSF, as well as other government and private funding sources.